Large-scale genetic analyses yielded the largest human metabolism map linking genetic variants to blood metabolites across ancestries, revealing regulators of lipid metabolism and disease risk genes. Separately, epitranscriptomic profiling methods enable precise abundance and location mapping of RNA modifications implicated in cancer and neurological disorders. These comprehensive molecular maps empower disease mechanism elucidation, biomarker discovery, and precision therapeutic target identification across metabolic and epigenetic landscapes.